[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 50.16.52.237. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Capitol Health Call
November 6, 2002

New FDA Commissioner

Author Affiliations
 

Not Available

Not Available

JAMA. 2002;288(17):2111. doi:10.1001/jama.288.17.2111

The Senate voted to confirm Mark B. McClellan, MD, PhD, as the new director of the US Food and Drug Administration (FDA). Although he has no regulatory experience, McClellan most recently served as a member of President Bush's Council of Economic Advisors, helping the administration form health care policies.

At his hearing before the Senate Health, Education, Labor, and Pensions Committee, McClellan vowed to speed approval of new drugs and devices while maintaining a commitment to health and safety.

First Page Preview View Large
First page PDF preview
First page PDF preview
×